Page 1 of 1

Gilenya users be on alert for shingles!

Posted: Mon Dec 22, 2014 2:24 pm
by 1eye
http://www.medpagetoday.com/Neurology/M ... osis/49214
The issue of zoster risk has come to the fore with fingolimod because of two fatal cases. One involved a clinical trial participant who died of a disseminated primary VZV infection in 2008 after taking the drug for 10 months. The second was reported in April 2013 and involved a case of reactivated zoster infection in a patient who had taken fingolimod in a postmarketing observational study for 6 months following treatment with natalizumab (Tysabri) and a 3-month washout period.